{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:04:45Z","timestamp":1789430685443,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Baiyin Science and Technology Plan Project","award":["No. 2025-2-17S"],"award-info":[{"award-number":["No. 2025-2-17S"]}]},{"name":"Baiyin Science and Technology Plan Project","award":["No. 2025-2-23S"],"award-info":[{"award-number":["No. 2025-2-23S"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28333-w","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:56:09Z","timestamp":1782712569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and associated factors of liver fibrosis and steatosis in Gansu, China: a community-based cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Junhong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xeuni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"28333_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"2","key":"28333_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337.","journal-title":"J Hepatol"},{"issue":"1","key":"28333_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen H, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Therapy. 2025;10(1):33.","journal-title":"Signal Transduct Target Therapy"},{"issue":"10308","key":"28333_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, et al. Liver cirrhosis. Lancet (London England). 2021;398(10308):1359\u201376.","journal-title":"Lancet (London England)"},{"issue":"4","key":"28333_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","volume":"6","author":"CL Hsu","year":"2024","unstructured":"Hsu CL, Loomba R. From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nat Metabolism. 2024;6(4):600\u20132.","journal-title":"Nat Metabolism"},{"issue":"1","key":"28333_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","volume":"11","author":"DQ Huang","year":"2025","unstructured":"Huang DQ, Wong VWS, Rinella ME, et al. Metabolic dysfunction-associated steatotic liver disease in adults. Nat Reviews Disease Primers. 2025;11(1):14.","journal-title":"Nat Reviews Disease Primers"},{"issue":"2","key":"28333_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review. JAMA. 2026;335(2):163\u201374.","journal-title":"JAMA"},{"issue":"4","key":"28333_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore MD). 2023;77(4):1335\u201347.","journal-title":"Hepatology (Baltimore MD)"},{"key":"28333_CR9","doi-asserted-by":"publisher","first-page":"101717","DOI":"10.1016\/j.lanwpc.2025.101717","volume":"64","author":"X Li","year":"2025","unstructured":"Li X, Zhou X-D, Wu J, et al. Pediatric MASLD in China: epidemiology, screening, diagnosis, and management. Lancet Reg Health Western Pac. 2025;64:101717.","journal-title":"Lancet Reg Health Western Pac"},{"issue":"2","key":"28333_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(2):389\u2013e9710.","journal-title":"Gastroenterology"},{"issue":"5","key":"28333_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology (Baltimore MD). 2017;65(5):1557\u201365.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"28333_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3350\/cmh.2025.0043","volume":"31","author":"S Shiina","year":"2025","unstructured":"Shiina S, Maikhuu J, Deng Q, et al. Liver disease trends in the Asia-Pacific region for the next 50 years. Clin Mol Hepatol. 2025;31(3):671\u201384.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"28333_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40121-022-00725-6","volume":"12","author":"Y Diao","year":"2022","unstructured":"Diao Y, Tang J, Wang X, et al. Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review. Infect Dis Therapy. 2022;12(1):53\u201366.","journal-title":"Infect Dis Therapy"},{"issue":"4","key":"28333_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, et al. Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China. Gastroenterology. 2023;165(4):1025\u201340.","journal-title":"Gastroenterology"},{"issue":"7","key":"28333_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/CM9.0000000000003141","volume":"138","author":"M Hou","year":"2024","unstructured":"Hou M, Gu Q, Cui J, et al. Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population. Chin Med J. 2024;138(7):829\u201337.","journal-title":"Chin Med J"},{"key":"28333_CR16","doi-asserted-by":"crossref","unstructured":"Unalp-Arida A, Ruhl CE. Prevalence of metabolic dysfunction-associated steatotic liver disease and fibrosis defined by liver elastography in the United States using National. Hepatology (Baltimore MD). 2024;82(5):1256\u201373. Health and Nutrition Examination Survey 2017-March 2020 and August 2021-August 2023 data.","DOI":"10.1097\/HEP.0000000000001211"},{"key":"28333_CR17","doi-asserted-by":"crossref","unstructured":"Zhao J, M\u00f3zes FE, Xu X-Y et al. Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study. MedComm. 2025;6(12):e70503.","DOI":"10.1002\/mco2.70503"},{"issue":"1","key":"28333_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1186\/s12889-024-18494-x","volume":"24","author":"W Gong","year":"2024","unstructured":"Gong W, Lin H, Ma X, et al. The regional disparities in liver disease comorbidity among elderly Chinese based on a health ecological model: the China Health and Retirement Longitudinal Study. BMC Public Health. 2024;24(1):1123.","journal-title":"BMC Public Health"},{"issue":"6","key":"28333_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"3","key":"28333_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"EASL Clinical Practice","year":"2021","unstructured":"EASL Clinical Practice. Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u2009\u2013\u20092021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"10","key":"28333_CR21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1136\/gutjnl-2025-335542","volume":"74","author":"G Feng","year":"2025","unstructured":"Feng G, Wong VW-S, Targher G, et al. Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring. Gut. 2025;74(10):1741\u201350.","journal-title":"Gut"},{"key":"28333_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clnu.2025.03.016","volume":"48","author":"H Fan","year":"2025","unstructured":"Fan H, Kouvari M, Guo C, et al. A comprehensive comparison of two commonly used BMI thresholds for non-communicable diseases and multimorbidity in the Chinese population. Clin Nutr. 2025;48:70\u20139.","journal-title":"Clin Nutr"},{"issue":"8","key":"28333_CR23","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/oby.24070","volume":"32","author":"M Al Hariri","year":"2024","unstructured":"Al Hariri M, Al-Sulaiti H, Anwardeen N, et al. Comparing the metabolic signatures of obesity defined by waist circumference, waist-hip ratio, or BMI. Obes (Silver Spring Md). 2024;32(8):1494\u2013507.","journal-title":"Obes (Silver Spring Md)"},{"issue":"13","key":"28333_CR24","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.cgh.2025.02.006","volume":"23","author":"GJK Ho","year":"2025","unstructured":"Ho GJK, Tan FXN, Sasikumar NA, et al. High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysis. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2025;23(13):2423\u2013e24321.","journal-title":"Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association"},{"key":"28333_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clnu.2025.01.019","volume":"46","author":"W Shi","year":"2025","unstructured":"Shi W, Suo X, Wang Y, et al. The associations between irregular breakfast and late-night snacking with metabolic dysfunction-associated steatotic liver disease. Clin Nutr. 2025;46:52\u20139.","journal-title":"Clin Nutr"},{"issue":"11","key":"28333_CR26","doi-asserted-by":"publisher","first-page":"e0797","DOI":"10.1097\/HC9.0000000000000797","volume":"9","author":"N Dunn","year":"2025","unstructured":"Dunn N, Zhang W, Blaney HL, et al. Physical activity and advanced fibrosis in MASLD, MetALD, and ALD in a nationally representative cohort: NHANES 2017\u20132020. Hepatol Commun. 2025;9(11):e0797.","journal-title":"Hepatol Commun"},{"issue":"1","key":"28333_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12986-025-00903-6","volume":"22","author":"D Zhao","year":"2025","unstructured":"Zhao D, Zheng X, Wang L, et al. Overlap prevalence and interaction effect of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease. Nutr Metabolism. 2025;22(1):10.","journal-title":"Nutr Metabolism"},{"issue":"3","key":"28333_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/joim.20103","volume":"298","author":"W Balkhed","year":"2025","unstructured":"Balkhed W, Bergram M, Iredahl F, et al. Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care. J Intern Med. 2025;298(3):173\u201387.","journal-title":"J Intern Med"},{"issue":"12","key":"28333_CR29","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.jhepr.2024.101193","volume":"6","author":"J Pustjens","year":"2024","unstructured":"Pustjens J, van Kleef LA, Janssen HLA, et al. Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD. JHEP Reports: Innov Hepatol. 2024;6(12):101193.","journal-title":"JHEP Reports: Innov Hepatol"},{"issue":"1","key":"28333_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s43856-025-01195-w","volume":"5","author":"Q Chen","year":"2025","unstructured":"Chen Q, Zhu Y, Gao J, et al. Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Commun Med. 2025;5(1):492.","journal-title":"Commun Med"},{"issue":"47","key":"28333_CR31","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.46234\/ccdcw2025.248","volume":"7","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liang X, Qi Y, et al. Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus - China, 2017\u20132024. China CDC Wkly. 2025;7(47):1483\u201390.","journal-title":"China CDC Wkly"},{"issue":"9","key":"28333_CR32","doi-asserted-by":"publisher","first-page":"100836","DOI":"10.1016\/j.jhepr.2023.100836","volume":"5","author":"Y-M Cheng","year":"2023","unstructured":"Cheng Y-M, Hsieh T-H, Wang C-C, et al. Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease. JHEP Reports: Innov Hepatol. 2023;5(9):100836.","journal-title":"JHEP Reports: Innov Hepatol"},{"issue":"8","key":"28333_CR33","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s40121-025-01189-0","volume":"14","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Su C, Li M, et al. Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis. Infect Dis Therapy. 2025;14(8):1599\u2013617.","journal-title":"Infect Dis Therapy"},{"issue":"3","key":"28333_CR34","first-page":"581","volume":"22","author":"S-C Huang","year":"2023","unstructured":"Huang S-C, Su T-H, Tseng T-C, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion. Clinical Gastroenterology and Hepatology: the Official Clinical Practice. J Am Gastroenterological Association. 2023;22(3):581\u2013e5906.","journal-title":"J Am Gastroenterological Association"},{"issue":"19","key":"28333_CR35","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.3390\/ijms26199594","volume":"26","author":"R Weiskirchen","year":"2025","unstructured":"Weiskirchen R, Lonardo A. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease. Int J Mol Sci. 2025;26(19):9594.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"28333_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40795-025-01032-2","volume":"11","author":"SA Qaisar","year":"2025","unstructured":"Qaisar SA, Moludi J, Shahnazi N, et al. Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort. BMC Nutr. 2025;11(1):47.","journal-title":"BMC Nutr"},{"issue":"6","key":"28333_CR37","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.clnu.2016.03.012","volume":"35","author":"S Marventano","year":"2016","unstructured":"Marventano S, Salomone F, Godos J, et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin Nutr. 2016;35(6):1269\u201381.","journal-title":"Clin Nutr"},{"key":"28333_CR38","doi-asserted-by":"crossref","unstructured":"Liu S, Li Q, Chen P et al. Association between dietary tea consumption and non-alcoholic fatty liver disease: a study based on Mendelian randomisation and National Health and Nutrition Examination Survey (2005\u20132018) association between tea and non-alcoholic fatty liver disease. Br J Nutr 2024;1\u201311.","DOI":"10.1017\/S0007114524002277"},{"issue":"2","key":"28333_CR39","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.pharmr.2024.100018","volume":"77","author":"X Zhang","year":"2024","unstructured":"Zhang X, Lau HC-H, Yu J. Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options. Pharmacol Rev. 2024;77(2):100018.","journal-title":"Pharmacol Rev"},{"issue":"24","key":"28333_CR40","doi-asserted-by":"publisher","first-page":"e70310","DOI":"10.1002\/mnfr.70310","volume":"69","author":"Z Liang","year":"2025","unstructured":"Liang Z, Sun X, Jin H, et al. Coffee and Tea Intake Is Inversely Associated With Hepatic Fat Deposition, Iron Deposition, and Fibroinflammation in the General Population. Mol Nutr Food Res. 2025;69(24):e70310.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"28333_CR41","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.aohep.2024.101753","volume":"30","author":"T Sukaram","year":"2024","unstructured":"Sukaram T, Maung ST, Chongpison Y, et al. Diagnostic performance of FibroTouch\u00ae in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience. Ann Hepatol. 2024;30(1):101753.","journal-title":"Ann Hepatol"},{"issue":"12","key":"28333_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/1751-2980.13242","volume":"24","author":"R Mu","year":"2023","unstructured":"Mu R, Xia YC, Zhu KY, et al. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard. J Dig Dis. 2023;24(12):691\u2013701.","journal-title":"J Dig Dis"},{"key":"28333_CR43","unstructured":"Zhang Y, Lee HW, Lin H et al. Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) 2025."},{"issue":"1","key":"28333_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.14309\/ajg.0000000000003455","volume":"121","author":"P Le","year":"2025","unstructured":"Le P, Tatar M, Rothberg MB, et al. Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2025;121(1):159\u201370.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28333-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:36:52Z","timestamp":1789429012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28333-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28333"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28333-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Baiyin Central Hospital (No. 2025BYSZXYYLL-0001). All procedures performed in the study were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants involved in the survey.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2591"}}